215 related articles for article (PubMed ID: 36331364)
21. Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study.
Löfvendahl S; Norlin JM; Schmitt-Egenolf M
Br J Dermatol; 2022 Jun; 186(6):970-976. PubMed ID: 34978071
[TBL] [Abstract][Full Text] [Related]
22. Generalized pustular psoriasis: overview of the status quo and results of a panel discussion.
Reich K; Augustin M; Gerdes S; Ghoreschi K; Kokolakis G; Mößner R; Mrowietz U; Navarini AA; Pinter A; Schäkel K; Staubach P; Sticherling M; Thaçi D; Wilsmann-Theis D
J Dtsch Dermatol Ges; 2022 Jun; 20(6):753-771. PubMed ID: 35674482
[TBL] [Abstract][Full Text] [Related]
23. Clinical profile of patients with acute generalized pustular psoriasis with and without IL36RN mutations in multi-ethnic Johor Bahru, Malaysia.
Choon SE; Tok PSK; Wong KW; Lim YT; Nanu NM; Barker JN; Capon F
Exp Dermatol; 2023 Aug; 32(8):1263-1271. PubMed ID: 36843152
[TBL] [Abstract][Full Text] [Related]
24. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
Bernardo D; Thaçi D; Torres T
Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
[TBL] [Abstract][Full Text] [Related]
25. Identifying patients with deteriorating generalized pustular psoriasis: Development of a prediction model.
Ohn J; Choi YG; Yun J; Jo SJ
J Dermatol; 2022 Jul; 49(7):675-681. PubMed ID: 35491617
[TBL] [Abstract][Full Text] [Related]
26. Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis.
Watanabe T; Yamaguchi Y; Watanabe Y; Takamura N; Aihara M
J Dermatol; 2020 Sep; 47(9):1033-1036. PubMed ID: 32613742
[TBL] [Abstract][Full Text] [Related]
27. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.
Krueger J; Puig L; Thaçi D
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):51-64. PubMed ID: 35061230
[TBL] [Abstract][Full Text] [Related]
28. Juvenile generalized pustular psoriasis with IL36RN mutation treated with short-term infliximab.
Pan J; Qiu L; Xiao T; Chen HD
Dermatol Ther; 2016 May; 29(3):164-7. PubMed ID: 26627198
[TBL] [Abstract][Full Text] [Related]
29. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
[TBL] [Abstract][Full Text] [Related]
30. A review of disease burden and clinical management for generalized pustular psoriasis in China.
Lu J; Shi Y
Expert Rev Clin Immunol; 2022 Oct; 18(10):1023-1032. PubMed ID: 36040447
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study.
Ohata C; Tsuruta N; Yonekura K; Higashi Y; Saito K; Katayama E; Imafuku S;
J Dermatol; 2022 Jan; 49(1):142-150. PubMed ID: 34723399
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and heterogeneity of generalized pustular psoriasis: A comparative study in a large retrospective cohort.
Xu Z; Liu Y; Qu H; Bai Y; Ma J; Hao J; Yu C; Dang E; Wang G; Shao S
Exp Dermatol; 2024 Jan; 33(1):e14891. PubMed ID: 37493071
[TBL] [Abstract][Full Text] [Related]
33. Generalized Pustular Psoriasis: Clinical Management and Update on Autoinflammatory Aspects.
Takeichi T; Akiyama M
Am J Clin Dermatol; 2020 Apr; 21(2):227-236. PubMed ID: 31813117
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States.
Noe MH; Wan MT; Mostaghimi A; Gelfand JM; ; Agnihothri R; Armstrong AW; Bhutani T; Bridges A; Brownstone N; Butt M; Duffin KPC; Carr C; Creadore A; DeNiro KL; Desai S; Dominguez AR; Duffy EK; Fairley JA; Femia A; Gudjonsson JE; Kaffenberger JA; Katz KL; Le ST; Martinez E; Maverakis E; Myers B; Naik HB; Nelson CA; Ortega-Loayza AG; Plovanich ME; Rangel LK; Ravi V; Reddy VD; Saleh JZ; Kirby JS; Sandhu JK; Shakshouk H; Shields BE; Sharif-Sidi Z; Smith J; Steahr A; Toussi A; Wanat KA; Wang B; Wei BM; Weinhammer A; Worswick SD; Yang A
JAMA Dermatol; 2022 Jan; 158(1):73-78. PubMed ID: 34878491
[TBL] [Abstract][Full Text] [Related]
35. Generalized Pustular Psoriasis: A Review of the Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment.
Reynolds KA; Pithadia DJ; Lee EB; Clarey D; Liao W; Wu JJ
Cutis; 2022 Aug; 110(2 Suppl):19-25. PubMed ID: 36219603
[TBL] [Abstract][Full Text] [Related]
36. SERPINA1, generalized pustular psoriasis, and adult-onset immunodeficiency.
Kantaputra P; Chaowattanapanit S; Kiratikanon S; Chaiwarith R; Choonhakarn C; Intachai W; Quarto N; Tongsima S; Ketudat Cairns JR; Ngamphiw C; McGrath JA; Chuamanochan M
J Dermatol; 2021 Oct; 48(10):1597-1601. PubMed ID: 34390020
[TBL] [Abstract][Full Text] [Related]
37. Clinical and genetic differences between pustular psoriasis subtypes.
Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States.
Hanna ML; Singer D; Bender SD; Valdecantos WC; Wu JJ
Curr Med Res Opin; 2021 Oct; 37(10):1697-1703. PubMed ID: 34289766
[TBL] [Abstract][Full Text] [Related]
39. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
Boehner A; Navarini AA; Eyerich K
Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
[TBL] [Abstract][Full Text] [Related]
40. Loss of Function
Kantaputra P; Daroontum T; Chuamanochan M; Chaowattanapanit S; Intachai W; Olsen B; Sastraruji T; Tongsima S; Ngamphiw C; Kampuansai J; Cox TC; Kiratikanon S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
